Low-dose compared to manufacturer-recommended dose four-factor prothrombin complex concentrate for acute warfarin reversal

被引：0
|
作者：
Wesley Zemrak
Francis Manuel
Kathryn E. Smith
Stephen Rolfe
Timothy Hayes
Robert L. Trowbridge
Brian Carlone
David Seder
机构：
[1] Maine Medical Center,Department of Pharmacy
[2] Mayo Clinic,Department of Pharmacy
[3] Maine Medical Center,Department of Pathology
[4] Maine Medical Center,Department of Medicine
[5] Maine Medical Center,Department of Critical Care Services
来源：
Journal of Thrombosis and Thrombolysis | 2019年 / 47卷
关键词：
Warfarin; Reversal; Prothrombin complex concentrate; Hemorrhage; PCC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：263 / 271
页数：8
相关论文
共 50 条
  • [41] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Denise H. Rhoney
    Mary La
    Molly Merz
    Aaron Cook
    Kent A. Owusu
    Christina Roels
    Joe Blunck
    Justin Shewmaker
    Kiranpal S. Sangha
    Salia Farrokh
    John Lewin
    Kathleen W. Chester
    Theresea Human
    Kathleen Bledsoe
    Kristy Greene
    Melissa Levesque
    Jody C. Rocker
    Gary Davis
    Ron Neyens
    Timothy F. Lassiter
    Sarah M. Adriance
    Neurocritical Care, 2021, 35 : 130 - 138
  • [42] High versus low fixed-dose four factor-prothrombin complex concentrate for warfarin reversal in patients with intracranial hemorrhage
    Compton, Frances
    Hall, Jeremy
    De Simone, Nicole
    Usmani, Amena
    Sarode, Ravi
    Burner, James
    TRANSFUSION AND APHERESIS SCIENCE, 2022, 61 (05)
  • [43] Three-Factor Versus Four-Factor Prothrombin Complex Concentrate for Warfarin Reversal-A Critical Appraisal of the Evidence
    Jones, G. Morgan
    Davidson, K. Erin
    AMERICAN JOURNAL OF THERAPEUTICS, 2018, 25 (03) : E375 - E377
  • [44] Four-factor Prothrombin Complex Concentrate for Reversal of Factor Xa Inhibitors versus Warfarin in Life-threatening Bleeding
    Rech, Megan A.
    Masic, Dalila
    Hammond, Drayton A.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2021, 22 (02) : 163 - 169
  • [45] Inactivated Four-Factor Prothrombin Complex Concentrate Dosing Practices for Reversal of Warfarin-Related Intracranial Hemorrhage
    Rhoney, Denise H.
    La, Mary
    Merz, Molly
    Cook, Aaron
    Owusu, Kent A.
    Roels, Christina
    Blunck, Joe
    Shewmaker, Justin
    Sangha, Kiranpal S.
    Farrokh, Salia
    Lewin, John
    Chester, Kathleen W.
    Human, Theresea
    Bledsoe, Kathleen
    Greene, Kristy
    Levesque, Melissa
    Rocker, Jody C.
    Davis, Gary
    Neyens, Ron
    Lassiter, Timothy F.
    Adriance, Sarah M.
    NEUROCRITICAL CARE, 2021, 35 (01) : 130 - 138
  • [46] FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR CARDIAC SURGERY BLEEDING OR ANTICOAGULATION REVERSAL
    Ahuja, Tania
    Li, Yihan
    Papadopoulos, John
    Pashun, Raymond
    Merchan, Cristian
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [47] Four-Factor Prothrombin Complex Concentrate for Coagulopathy Reversal in Patients With Liver Disease
    Huang, Wan-Ting
    Cang, William C.
    Derry, Katrina L.
    Lane, James R.
    von Drygalski, Annette
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2017, 23 (08) : 1028 - 1035
  • [48] Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate
    Jansma, Brianna
    Montgomery, Josephine
    Dietrich, Scott
    Mixon, Mark A.
    Peksa, Gary D.
    Faine, Brett
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (11) : 1090 - 1095
  • [49] Evaluation of fixed dose 4-factor prothrombin complex concentrate for emergent warfarin reversal
    Klein, Lauren
    Peters, Jessica
    Miner, James
    Gorlin, Jed
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (09): : 1213 - 1218
  • [50] COLLABORATIVE PRESCRIBING OF FOUR-FACTOR PROTHROMBIN COMPLEX CONCENTRATE FOR EMERGENT ANTICOAGULATION REVERSAL
    Tran, Kenneth K.
    Telford, Evan D.
    Hendrickson, Andrew L.
    Franck, Andrew
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 2136 - 2136
12345